EVD CSF Sampling: Closed-System Questions Buyers Raise

CSF sampling from an EVD means deliberately opening a closed drainage system, which is why buyers and infection prevention teams ask detailed questions about it. They want to know where samples are taken, how the access point is protected, how the technique is taught and how the device supports the hospital’s sampling protocol. Honest, IFU-based answers matter more than features.

Cerebrospinal fluid samples are central to diagnosing drain-related ventriculitis and to monitoring patients after hemorrhage or infection. At the same time, every access to the system is a potential route for contamination. Consensus guidance on EVD management and infectious disease guidelines on healthcare-associated ventriculitis both give attention to how and when CSF is sampled. This article covers the questions distributors hear and how to answer them responsibly.

Why is CSF sampling a closed-system issue?

An EVD is designed as a closed system from the catheter tip in the ventricle to the drainage bag. Bacteria that enter the system can travel toward the patient, which is why EVD care emphasizes keeping the system closed. Sampling, flushing, bag changes and disconnections are the moments when that closure is broken.

Hospitals therefore treat sampling as part of their EVD infection prevention bundle. The device cannot make sampling safe on its own, but its design determines where access happens, how easily aseptic technique can be followed and how clearly nurses can be taught.

For a buyer, the practical consequence is that sampling questions are not a side issue. They often decide whether infection prevention supports or opposes a change of system, and infection prevention has a strong voice on most value-analysis committees.

What questions do buyers and infection teams ask?

In evaluations, the same questions come up repeatedly:

• Where on the system is CSF sampled, and how close is that point to the patient?
• How is the access point protected between uses?
• What does the Instructions for Use say about the sampling sequence?
• Does sampling require any disconnection, or can it be done without opening the line?
• How is the sample kept from being contaminated by fluid that has been standing in the drip chamber?
• What training materials does the supplier provide for nurses and residents?

The honest answer to most of these comes from the Instructions for Use of the specific configuration. Sit down with the infection preventionist and the nurse educator, walk through the IFU together on a demonstration unit, and identify each access point and the steps described for it. If a question is not answered in the IFU, send it to the manufacturer and return with a written reply.

How often should CSF be sampled?

Sampling frequency is a clinical and protocol decision. Some units sample routinely at fixed intervals; others sample only when there is a clinical indication. Consensus guidance on EVD management discusses limiting unnecessary access to the system, and many hospitals have moved toward indication-based sampling for that reason. A distributor should not take a position on frequency. What a distributor can do is make sure the device and the training support whatever protocol the hospital follows.

Frequency also affects purchasing in a small way. Each sampling event uses consumables such as syringes, caps and specimen containers, which are not part of the drainage kit. When the hospital changes its sampling protocol, the materials manager may ask the distributor what else changes. The answer is usually nothing in the EVD assortment itself, but showing that you have considered the question builds trust.

Where does the sample come from, and why does it matter?

Fluid that has collected in the drip chamber or bag has been outside the patient for some time and is not representative for diagnostic purposes. Clinical protocols therefore describe taking samples from a point close to the patient, using aseptic technique and, in many protocols, discarding a small initial volume before collecting the sample. The exact sequence varies by hospital.

When presenting a DESU system, show the infection team the full fluid path, from the catheter to the drip chamber to the bag, and explain which part of the system the IFU designates for access. On the EVD-010 Series, the path runs from the 31 cm ventricular catheter to the 150 ml drip chamber on its 30 cm measuring scale and on to the 800 ml drainage bag. On the EVD-020 Series, it runs from a ventricular or lumbar catheter through the drip chamber, with its filter, to the bag.

How should sampling technique be taught?

Infection prevention teams value suppliers who support consistent technique. A distributor can help by organizing hands-on practice and by providing materials that follow the IFU exactly. A useful sampling module covers the elements below, while the clinical details come from the hospital’s own protocol.

Where does catheter choice fit in?

Some hospitals combine careful sampling practice with antibiotic-impregnated catheters as part of a wider bundle. DESU’s antibiotic-impregnated catheters, including the ventricular catheter kit in its orange version, are designed to release the agent in a controlled way over 28 days. That is a separate measure from sampling technique and does not reduce the importance of keeping the system closed. Infection teams may also ask whether the catheter affects how CSF culture results are interpreted; route that question to the manufacturer for a documented answer.

What documentation do infection teams expect?

Infection preventionists approach a new EVD system with a document checklist. Having the materials ready before the first meeting shortens the evaluation and shows that the supplier takes infection prevention seriously. Typical requests include:

• The Instructions for Use, with the sections on handling, access and bag changes marked.
• Sterilization method and packaging information for each component.
• Shelf life and storage conditions.
• A description of the catheter versions available and how the antibiotic-impregnated version is identified.
• The manufacturer’s quality certificates, such as ISO 13485, and the CE certificate.
• Training materials the supplier will provide, including any sampling module.
• A contact route for reporting product issues and receiving written responses.

Ask the infection preventionist early which of these the committee needs in its own format. Some hospitals use a standard product evaluation form that the supplier completes; filling it carefully and completely is often the first impression the team has of the manufacturer.

What should a distributor never say about sampling?

Credibility with infection prevention depends on precise language:

• Do not describe any system as “infection-proof” or claim it makes sampling risk-free.
• Do not recommend a sampling frequency or a discard volume.
• Do not improvise a sampling sequence that is not in the IFU.
• Do not compare infection rates between systems without a published source the team can read.

Instead, show the device clearly, provide the IFU, offer training and promise written answers. DESU manufactures its EVD systems in its own facility in Ankara, Türkiye, under ISO 13485, and its products carry the CE mark, so technical questions can be answered by the people responsible for the design.

Talk to a DESU product specialist

If an infection prevention team has asked about CSF sampling on DESU drainage systems, our product specialists can walk through the IFU with you and provide documented answers for your market. Email sales@desu.tr or use the contact page.